Symbol="XBIT"
AssetType="Common Stock"
Name="XBiotech Inc"
Description="XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. The company is headquartered in Austin, Texas."
CIK="1626878"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8201 E. RIVERSIDE DRIVE, BUILDING 4, SUITE 100, AUSTIN, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="164068000"
EBITDA="-31443000"
PERatio="None"
PEGRatio="0"
BookValue="7.78"
DividendPerShare="0"
DividendYield="0"
EPS="-0.93"
RevenuePerShareTTM="0.115"
ProfitMargin="0"
OperatingMarginTTM="-9.63"
ReturnOnAssetsTTM="-0.0823"
ReturnOnEquityTTM="-0.125"
RevenueTTM="3510000"
GrossProfitTTM="3359000"
DilutedEPSTTM="-0.93"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.933"
AnalystTargetPrice="18"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.9"
PriceToBookRatio="0.405"
EVToRevenue="0.686"
EVToEBITDA="3.944"
Beta="1.238"
num_52WeekHigh="6.69"
num_52WeekLow="3"
num_50DayMovingAverage="4.99"
num_200DayMovingAverage="3.919"
SharesOutstanding="30439300"
DividendDate="2021-07-23"
ExDividendDate="2021-07-15"
symbol="XBIT"
open="5.50"
high="5.66"
low="5.17"
price="5.20"
volume="39097.00"
latest_trading_day="2023-07-14"
previous_close="5.49"
change="-0.29"
change_percent="-5.2823%"
aroon_positive_momentum_days="66"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="68165"
Change_recent_avg="0.01"
Delta_recent_avg="0.28"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="1148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_negative_thumbnail_id_2="109"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="600"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0108.jpeg"
image_positive_thumbnail_id_2="703"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
